Drug metabolism in drug discovery and development
www.ncbi.nlm.nih.gov › pmc › articlesApr 12, 2018 · Drug discovery and development is a time-consuming and costly process. Based on the study by the Tufts Center for the Study of Drug Development (2016)1, on average, it takes more than 10 years and over $2.6 billion to develop a new drug. One of the biggest challenges for the pharmaceutical research community is therefore to execute an optimal process for drug discovery and development.
Role of pharmacogenomics in drug discovery and development
www.ncbi.nlm.nih.gov › pmc › articlesTime factor in drug development. Drug discovery and development is an elaborate and time consuming process. The average time taken from synthesis of a new chemical entity (NCE) to its marketing has increased from an average of 7.9 years in 1960 to an average of about 9 to 12 years in 1990. It includes two major phases, phase I being the discovery of the drug compound, which is the most crucial stage in drug development, and phase II being animal and clinical studies followed by marketing.
Bioinformatics in drug development and assessment
pubmed.ncbi.nlm.nih.gov › 15931766Abstract. Bioinformatics is playing an increasingly important role in nearly all aspects of drug discovery, drug assessment, and drug development. This growing importance lies not only in the role that bioinformatics plays in handling large volumes of data, but also in the utility of bioinformatics tools to predict, analyze, or help interpret clinical and preclinical findings.
Bioinformatics in drug development and assessment
https://pubmed.ncbi.nlm.nih.gov/15931766Bioinformatics is playing an increasingly important role in nearly all aspects of drug discovery, drug assessment, and drug development. This growing importance lies not only in the role that bioinformatics plays in handling large volumes of data, but also in the utility of bioinformatics tools to predict, analyze, or help interpret clinical and preclinical findings.